SUSAN GOMINGER: Open Payments
NPI 1215013198 · PAULSBORO, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,001 in 44 payments from 16 companies in 2025. Trend: 2023 $814 · 2024 $530 · 2025 $1,001
Food & beverage: $866Education: $135
| Company | Payments | Amount |
|---|---|---|
| MILLICENT US INC | 4 | $189 |
| Astellas Pharma US Inc | 9 | $159 |
| Sumitomo Pharma America, Inc. | 6 | $107 |
| Biogen, Inc. | 1 | $101 |
| SHIELD THERAPEUTICS INC | 3 | $72 |
| Exeltis, USA Inc. | 4 | $67 |
| Hologic Sales and Service, LLC | 3 | $59 |
| Sage Therapeutics, LLC | 3 | $49 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $42 |
| ABBVIE INC. | 2 | $32 |
Products named: Veozah, ZURZUVAE, MYFEMBREE, ACCRUFER, SLYND, APTIMA, LILETTA, Cologuard Collection Kit.
Industry payments across NJ — which companies pay providers there.
